Dysregulation of NF-κB is a major driver in the pathogenesis of many haematological malignancies, including lymphoma, where it initiates and maintains an anti-apoptotic and pro-proliferative gene expression programme [40]. The gene discussed is NFKB1; the disease is lymphoma.